CN112535760A - Repair type medical cold compress dressing - Google Patents
Repair type medical cold compress dressing Download PDFInfo
- Publication number
- CN112535760A CN112535760A CN202011574947.5A CN202011574947A CN112535760A CN 112535760 A CN112535760 A CN 112535760A CN 202011574947 A CN202011574947 A CN 202011574947A CN 112535760 A CN112535760 A CN 112535760A
- Authority
- CN
- China
- Prior art keywords
- extract
- percent
- cold compress
- medical cold
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008439 repair process Effects 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 73
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 12
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 12
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 12
- 239000000419 plant extract Substances 0.000 claims abstract description 10
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 9
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 9
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000006002 Pepper Substances 0.000 claims abstract description 9
- 235000004347 Perilla Nutrition 0.000 claims abstract description 9
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 9
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 9
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 9
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 9
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 9
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 9
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims abstract description 9
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 9
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims abstract description 9
- 229940025878 hesperidin Drugs 0.000 claims abstract description 9
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 9
- 229940016667 resveratrol Drugs 0.000 claims abstract description 9
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108010024636 Glutathione Proteins 0.000 claims abstract description 6
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 6
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 6
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 6
- 229940116229 borneol Drugs 0.000 claims abstract description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 150000002148 esters Chemical class 0.000 claims abstract description 6
- 229960003180 glutathione Drugs 0.000 claims abstract description 6
- 235000021239 milk protein Nutrition 0.000 claims abstract description 6
- 235000008390 olive oil Nutrition 0.000 claims abstract description 6
- 239000004006 olive oil Substances 0.000 claims abstract description 6
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- 239000008170 walnut oil Substances 0.000 claims abstract description 6
- 239000001628 zingiber officinale rosc. oil terpeneless Substances 0.000 claims abstract description 6
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 5
- 244000124853 Perilla frutescens Species 0.000 claims abstract 3
- 244000203593 Piper nigrum Species 0.000 claims abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 10
- 235000013793 astaxanthin Nutrition 0.000 claims description 10
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 10
- 229940022405 astaxanthin Drugs 0.000 claims description 10
- 239000001168 astaxanthin Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical group OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 claims description 8
- 244000178870 Lavandula angustifolia Species 0.000 claims description 7
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 7
- 241001071917 Lithospermum Species 0.000 claims description 7
- 244000170916 Paeonia officinalis Species 0.000 claims description 7
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 7
- 235000020710 ginseng extract Nutrition 0.000 claims description 7
- 239000001102 lavandula vera Substances 0.000 claims description 7
- 235000018219 lavender Nutrition 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 7
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 244000192528 Chrysanthemum parthenium Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000004130 lipolysis Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract description 3
- 230000003467 diminishing effect Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 240000007890 Leonurus cardiaca Species 0.000 abstract 2
- 241000207925 Leonurus Species 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 241000229722 Perilla <angiosperm> Species 0.000 description 6
- 241000722363 Piper Species 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940127130 immunocytokine Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a repair type medical cold compress dressing which comprises the following substances: milk protein, serine, folium artemisiae argyi extract, apple fruit extract, perilla extract, resveratrol, sodium hyaluronate, motherwort extract, pepper seed extract, hesperidin, perilla seed oil, walnut oil, olive oil, borneol, an emulsifier, polyglycerol-6 esters, ginger root oil, glutathione, a plant extract and water. The repairing medical cold compress dressing has the functions of balancing internal secretion and improving immunity, is rich in extracts of effective components such as resveratrol, folium artemisiae argyi, sodium hyaluronate, serine, motherwort herb, pepper seed, purple perilla, hesperidin and the like, can effectively promote the lipolysis process and metabolism, further eliminates orange peel tissues, is matched with effective plant extracts, activates a blood circulation system in a body and has the effects of diminishing inflammation and relieving pain, does not bring pain to skin when in use, and is high in mildness.
Description
Technical Field
The invention relates to the technical field of medical dressings, in particular to a repair type medical cold compress dressing.
Background
Skin is an important barrier for the human body against external damage. In daily life, skin injuries are common, such as skin abrasion, contusion, slight cut, slight scald, burn, sunburn, slight medical and cosmetic operation and other accidents or skin local superficial wound injuries caused by diseases, after the skin barrier is injured, the resistance is reduced, external bacteria are easily infected, and the phenomena of small amount of bleeding, tissue fluid exudation and the like are caused when the skin barrier of inflammation reactions such as pruritus, red swelling, stabbing pain and other parts is injured. Therefore, the medical dressing is usually applied to repair and nursing of skin barriers, and can play important roles in protecting wounds, preventing infection, repairing, promoting wound healing and the like. However, the existing medical dressing can not effectively promote the lipolysis process and the metabolism.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a repair type medical cold compress dressing which can permeate into the human body through skin and glands to play a role in repairing cells, supplementing energy and dredging channels and collaterals.
The technical purpose of the invention is realized by the following technical scheme: the repair type medical cold compress dressing comprises the following substances in percentage by mass:
milk protein: 5.0 to 10.0 percent;
serine: 1.0-2.5%;
the folium artemisiae argyi extract: 1.0 to 3.5 percent;
apple fruit extract: 2.0-4.0%;
and (3) perilla extract: 1.0-3.0%;
resveratrol: 3.0 to 5.0 percent;
sodium hyaluronate: 4.0 to 6.0 percent;
motherwort extract: 1.0-3.0%;
pepper seed extract: 1.0-3.0%;
hesperidin: 2.0 to 3.0 percent;
purple perilla seed oil: 1.0 to 3.5 percent;
walnut oil: 2.0 to 3.0 percent;
olive oil: 1.0-3.0%;
borneol: 0.2 to 0.5 percent;
emulsifier: 0.05 to 1.5 percent;
polyglycerol-6 esters: 0.05 to 1.0 percent
Ginger root oil: 1.0-3.0%;
glutathione: 1.0-3.0%;
plant extracts: 10.5 to 28.0 percent;
water: and (4) the balance.
Further, the plant extract comprises lithospermum extract, ginseng extract, peony root bark extract, notopterygium root extract and ginger root extract; the contents of the lithospermum extract, the ginseng extract, the peony root bark extract, the notopterygium root extract and the ginger root extract are respectively 2.0-4.0%, 2.0-5.0%, 1.0-3.0%, 4.0-6.0% and 2.0-4.0%.
Further, the plant extract also comprises oat extract; the content of the oat extract is 1.0-3.0%.
Further, the folium artemisiae argyi extract is prepared by cleaning folium artemisiae argyi, adding water, performing ultrasonic extraction, filtering, and concentrating the filtrate; wherein the ultrasonic power is 350-380W, and the extraction time is 40-45 min.
Further, the preparation method of the motherwort extract comprises the steps of grinding motherwort into powder, adding ethanol water solution, carrying out ultrasonic extraction with the ultrasonic power of 350-400W and the extraction time of 25-30min, filtering, extracting filtrate with diethyl ether, removing an organic solvent layer, heating at 50-55 ℃ for 10-15min, centrifuging to obtain supernatant, and concentrating the supernatant.
Further, lavender essential oil and astaxanthin are also included; the contents of lavender essential oil and astaxanthin are 1.5-3.0% and 2.0-3.0%, respectively.
Further, the emulsifier is PEG-6.
In conclusion, the invention has the following beneficial effects:
1. the repairing medical cold compress dressing has the functions of balancing internal secretion and improving immunity, is rich in extracts of effective components such as resveratrol, folium artemisiae argyi, sodium hyaluronate, serine, motherwort herb, pepper seed, purple perilla, hesperidin and the like, can effectively promote the lipolysis process and metabolism, further eliminates orange peel tissues, is matched with effective plant extracts, activates a blood circulation system in a body and has the effects of diminishing inflammation and relieving pain, does not bring pain to skin when in use, and is high in mildness.
2. The motherwort extract is added, so that the Chinese medicinal preparation has the special effects of promoting blood circulation to restore menstrual flow, removing blood stasis and promoting tissue regeneration.
Detailed Description
In order to make the objects, technical solutions and advantages of the present application more apparent, the present application is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the present application and are not intended to limit the present application.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, and the terms used herein in the specification of the present invention are for the purpose of describing particular embodiments only and are not intended to limit the present invention.
Example 1:
the repair type medical cold compress dressing comprises the following substances in percentage by mass:
milk protein: 10.0 percent; serine: 2.5 percent; the folium artemisiae argyi extract: 2.5 percent; apple fruit extract: 3.0 percent; and (3) perilla extract: 3.0 percent; resveratrol: 3.0 percent; sodium hyaluronate: 4.0 percent; motherwort extract: 2.0 percent; pepper seed extract: 2.0 percent; hesperidin: 2.5 percent; purple perilla seed oil: 2.5 percent; walnut oil: 2.0 percent; olive oil: 3.0 percent; borneol: 0.2 percent; PEG-6: 1.0 percent; polyglycerol-6 esters: 1.0 percent; ginger root oil: 2.0 percent; glutathione: 2.0 percent; and (3) extracting the lithospermum: 2.0 percent; the ginseng extract: 2.0 percent; peony root bark extract: 2.0 percent; notopterygium root extract: 4.0 percent; ginger root extract: 3.0 percent; and (3) oat extract: 2.0 percent; lavender essential oil: 2.0 percent; astaxanthin: 3.0 percent; water: and (4) the balance.
Wherein the folium Artemisiae Argyi extract is prepared by cleaning folium Artemisiae Argyi, adding water, performing ultrasonic extraction, filtering, and concentrating the filtrate; wherein the ultrasonic power is 350W, and the extraction time is 30 min.
The preparation method of herba Leonuri extract comprises grinding herba Leonuri into powder, adding ethanol water solution, performing ultrasonic extraction with ultrasonic power of 380W for 30min, filtering, extracting the filtrate with diethyl ether, removing organic solvent layer, heating at 55 deg.C for 10min, centrifuging to obtain supernatant, and concentrating the supernatant.
The preparation method of the repair type medical cold compress dressing comprises the following steps: weighing the components in the formula according to a proportion, firstly adding PEG-6 and astaxanthin into water, stirring uniformly, then adding the rest components in sequence, and after adding one component every time, adding the next component after stirring uniformly to obtain the repair type medical cold compress dressing which is uniformly mixed.
Example 2:
the repair type medical cold compress dressing comprises the following substances in percentage by mass:
milk protein: 8.0 percent; serine: 2.0 percent; the folium artemisiae argyi extract: 1.5 percent; apple fruit extract: 3.5 percent; and (3) perilla extract: 2.0 percent; resveratrol: 4.0 percent; sodium hyaluronate: 4.0 percent; motherwort extract: 2.5 percent; pepper seed extract: 2.0 percent; hesperidin: 2.0 percent; purple perilla seed oil: 3.5 percent; walnut oil: 2.5 percent; olive oil: 2.5 percent; borneol: 0.2 percent; PEG-6: 1.0 percent; polyglycerol-6 esters: 1.0 percent; ginger root oil: 2.5 percent; glutathione: 2.0 percent; and (3) extracting the lithospermum: 1.0 percent; the ginseng extract: 3.0 percent; peony root bark extract: 1.0 percent; notopterygium root extract: 4.0 percent; ginger root extract: 2.0 percent; and (3) oat extract: 2.0 percent; lavender essential oil: 1.5 percent; astaxanthin: 2.5 percent; water: and (4) the balance.
Wherein the folium Artemisiae Argyi extract is prepared by cleaning folium Artemisiae Argyi, adding water, performing ultrasonic extraction, filtering, and concentrating the filtrate; wherein the ultrasonic power is 350W, and the extraction time is 30 min.
The preparation method of herba Leonuri extract comprises grinding herba Leonuri into powder, adding ethanol water solution, performing ultrasonic extraction with ultrasonic power of 380W for 30min, filtering, extracting the filtrate with diethyl ether, removing organic solvent layer, heating at 55 deg.C for 10min, centrifuging to obtain supernatant, and concentrating the supernatant.
The preparation method of the repair type medical cold compress dressing comprises the following steps: weighing the components in the formula according to a proportion, firstly adding PEG-6 and astaxanthin into water, stirring uniformly, then adding the rest components in sequence, and after adding one component every time, adding the next component after stirring uniformly to obtain the repair type medical cold compress dressing which is uniformly mixed.
Example 3:
the repair type medical cold compress dressing comprises the following substances in percentage by mass:
milk protein: 9.0 percent; serine: 1.0 percent; the folium artemisiae argyi extract: 1.5 percent; apple fruit extract: 2.5 percent; and (3) perilla extract: 1.0 percent; resveratrol: 3.0 percent; sodium hyaluronate: 4.5 percent; motherwort extract: 1.5 percent; pepper seed extract: 2.0 percent; hesperidin: 3.0 percent; purple perilla seed oil: 2.5 percent; walnut oil: 3.0 percent; olive oil: 2.0 percent; borneol: 0.2 percent; PEG-6: 1.0 percent; polyglycerol-6 esters: 1.0 percent; ginger root oil: 1.0 percent; glutathione: 2.0 percent; and (3) extracting the lithospermum: 1.0 percent; the ginseng extract: 2.0 percent; peony root bark extract: 2.0 percent; notopterygium root extract: 4.0 percent; ginger root extract: 3.0 percent; and (3) oat extract: 1.0 percent; lavender essential oil: 1.5 percent; astaxanthin: 2.0 percent; water: and (4) the balance.
Wherein the folium Artemisiae Argyi extract is prepared by cleaning folium Artemisiae Argyi, adding water, performing ultrasonic extraction, filtering, and concentrating the filtrate; wherein the ultrasonic power is 350W, and the extraction time is 30 min.
The preparation method of herba Leonuri extract comprises grinding herba Leonuri into powder, adding ethanol water solution, performing ultrasonic extraction with ultrasonic power of 380W for 30min, filtering, extracting the filtrate with diethyl ether, removing organic solvent layer, heating at 55 deg.C for 10min, centrifuging to obtain supernatant, and concentrating the supernatant.
The preparation method of the repair type medical cold compress dressing comprises the following steps: weighing the components in the formula according to a proportion, firstly adding PEG-6 and astaxanthin into water, stirring uniformly, then adding the rest components in sequence, and after adding one component every time, adding the next component after stirring uniformly to obtain the repair type medical cold compress dressing which is uniformly mixed.
Comparative example 1:
comparative example 1 no serine was added, and other ingredients and preparation method were the same as example 1.
Comparative example 2:
comparative example 2 the leonurus extract was not added, and other ingredients and preparation methods were the same as example 1.
And (3) effect testing:
the products obtained in examples 1 to 3 were tested for their effects with the products of comparative examples 1 to 2:
150 patients with rheumatism were selected and randomly divided into 5 groups, and the products of examples 1-3 and comparative examples 1-2 were used, respectively, all patients could use the products as required for 15 days continuously, and the curative effect statistics are as follows.
Wherein, the evaluation standard of the curative effect is as follows:
the effect is shown: the symptoms of rheumatism and pain are obviously improved;
the method has the following advantages: the symptoms are improved and improved, and the pain symptoms are relieved;
and (4) invalidation: the symptoms did not improve or improve, or even tended to be more severe.
| Test items | Show effect | Is effective | Invalidation | Significant efficiency (%) |
| Example 1 | 49 | 1 | 0 | 98％ |
| Example 2 | 48 | 2 | 0 | 96％ |
| Example 3 | 48 | 2 | 0 | 96％ |
| Comparative example 1 | 34 | 16 | 0 | 68％ |
| Comparative example 2 | 30 | 15 | 5 | 60％ |
The data in the table show that the medical cold compress dressing has obvious curative effect on treating rheumatism and eliminating pain. The repairing medical cold compress dressing has the functions of balancing internal secretion and improving immunity, is rich in extracts of effective components such as resveratrol, folium artemisiae argyi, sodium hyaluronate, serine, motherwort herb, pepper seed, purple perilla, hesperidin and the like, can effectively promote the lipolysis process and metabolism, further eliminates orange peel tissues, is matched with effective plant extracts, activates a blood circulation system in a body and has the effects of diminishing inflammation and relieving pain, does not bring pain to skin when in use, and is high in mildness.
Among them, comparative example 1 showed a decrease in the significant efficiency to 68% without adding serine, and thus it was found that serine plays an important role in the metabolism of fats and fatty acids and the growth of muscles, and contributes to the production of immunocytokines and antibodies, thereby maintaining a healthy immune system.
In the case that the leonurus extract is not added, the significant efficiency is reduced to 60%, and the condition that the use is invalid occurs at the same time, so that the leonurus extract plays an important role in the medical cold compress dressing, and the effects of promoting blood circulation to regulate menstruation, removing blood stasis and promoting tissue regeneration of the medical cold compress dressing can be obviously improved by adding the leonurus extract.
The above description is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiments, and all technical solutions belonging to the idea of the present invention belong to the protection scope of the present invention. It should be noted that modifications and embellishments within the scope of the invention may occur to those skilled in the art without departing from the principle of the invention, and are considered to be within the scope of the invention.
Claims (7)
1. The repairing medical cold compress dressing is characterized by comprising the following substances in percentage by mass:
milk protein: 5.0 to 10.0 percent;
serine: 1.0-2.5%;
the folium artemisiae argyi extract: 1.0 to 3.5 percent;
apple fruit extract: 2.0-4.0%;
and (3) perilla extract: 1.0-3.0%;
resveratrol: 3.0 to 5.0 percent;
sodium hyaluronate: 4.0 to 6.0 percent;
motherwort extract: 1.0-3.0%;
pepper seed extract: 1.0-3.0%;
hesperidin: 2.0 to 3.0 percent;
purple perilla seed oil: 1.0 to 3.5 percent;
walnut oil: 2.0 to 3.0 percent;
olive oil: 1.0-3.0%;
borneol: 0.2 to 0.5 percent;
emulsifier: 0.05 to 1.5 percent;
polyglycerol-6 esters: 0.05 to 1.0 percent
Ginger root oil: 1.0-3.0%;
glutathione: 1.0-3.0%;
plant extracts: 10.5 to 28.0 percent;
water: and (4) the balance.
2. The restorative-type medical cold compress dressing of claim 1, wherein the plant extract comprises a lithospermum erythrorhizon extract, a ginseng extract, a peony root bark extract, a notopterygium root extract, and a ginger root extract; the contents of the lithospermum extract, the ginseng extract, the peony root bark extract, the notopterygium root extract and the ginger root extract are respectively 2.0-4.0%, 2.0-5.0%, 1.0-3.0%, 4.0-6.0% and 2.0-4.0%.
3. The prosthetic medical cold compress dressing of claim 2, wherein the plant extract further comprises oat extract; the content of the oat extract is 1.0-3.0%.
4. The repair type medical cold compress dressing according to claim 2, wherein the folium artemisiae argyi extract is prepared by cleaning folium artemisiae argyi, adding water, performing ultrasonic extraction, filtering, and concentrating the filtrate; wherein the ultrasonic power is 350-380W, and the extraction time is 40-45 min.
5. The repair type medical cold compress dressing as claimed in claim 2, wherein the herba Leonuri extract is prepared by grinding herba Leonuri into powder, adding ethanol water solution, performing ultrasonic extraction with ultrasonic power of 350-400W for 25-30min, filtering, extracting the filtrate with diethyl ether, removing organic solvent layer, heating at 50-55 deg.C for 10-15min, centrifuging to obtain supernatant, and concentrating the supernatant.
6. The repair medical cold compress dressing of claim 1, further comprising lavender essential oil and astaxanthin; the contents of lavender essential oil and astaxanthin are 1.5-3.0% and 2.0-3.0%, respectively.
7. The repair medical cold compress dressing according to claim 1, wherein the emulsifier is PEG-6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011574947.5A CN112535760A (en) | 2020-12-28 | 2020-12-28 | Repair type medical cold compress dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011574947.5A CN112535760A (en) | 2020-12-28 | 2020-12-28 | Repair type medical cold compress dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112535760A true CN112535760A (en) | 2021-03-23 |
Family
ID=75017688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011574947.5A Pending CN112535760A (en) | 2020-12-28 | 2020-12-28 | Repair type medical cold compress dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112535760A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110101639A (en) * | 2019-06-17 | 2019-08-09 | 广州南雪药业有限公司 | Vigor frost and preparation method thereof |
| CN111568780A (en) * | 2020-05-09 | 2020-08-25 | 广东华辰凯太健康管理有限公司 | Herbal gel with myotonin and preparation method thereof |
| CN112089883A (en) * | 2020-09-14 | 2020-12-18 | 海南希睿达生物技术有限公司 | Medical cold compress dressing and preparation method thereof |
-
2020
- 2020-12-28 CN CN202011574947.5A patent/CN112535760A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110101639A (en) * | 2019-06-17 | 2019-08-09 | 广州南雪药业有限公司 | Vigor frost and preparation method thereof |
| CN111568780A (en) * | 2020-05-09 | 2020-08-25 | 广东华辰凯太健康管理有限公司 | Herbal gel with myotonin and preparation method thereof |
| CN112089883A (en) * | 2020-09-14 | 2020-12-18 | 海南希睿达生物技术有限公司 | Medical cold compress dressing and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 周秋丽等: "《现代中药基础研究与临床》", 30 June 2012, 天津科技翻译出版公司 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113520896A (en) | Composition with acne removing and acne mark repairing functions and preparation method thereof | |
| CN111529470A (en) | Gel for removing acne and soothing allergy and preparation method thereof | |
| CN101837082B (en) | Chinese preparation for treating burn without leaving scar | |
| CN106581439A (en) | Traditional Chinese medicine composition for treating wounds, diabetic feet and skin ulceration, and preparation method thereof | |
| CN109223631B (en) | External natural anti-inflammatory composition and preparation method and application thereof | |
| CN112535760A (en) | Repair type medical cold compress dressing | |
| CN106822321B (en) | Application of Curcuma water of traumatology in preparing medicine for treating keratosis pilaris | |
| CN104173749A (en) | Drug for repairing burn and scald | |
| CN104644501A (en) | Composition with acne removal and restoration effects and preparation method thereof | |
| CN103655948A (en) | Traditional Chinese veterinary medicine injection for treating cow mastitis and preparation method thereof | |
| CN112656989A (en) | Yang warming type medical cold compress dressing | |
| CN114712273A (en) | Acne-removing repairing composition and application thereof | |
| CN111035708A (en) | Olive oil aloe burn cream | |
| CN104173750A (en) | Drug for scald | |
| CN109331106B (en) | Red medicine preparation for wound repair and preparation method thereof | |
| CN110448666B (en) | Formula essential oil for treating burns and scalds | |
| CN111686189B (en) | Plant composition for treating red wind buttocks and application thereof | |
| CN105232650A (en) | Unguent for treating scalds and preparation and application methods thereof | |
| CN114246825A (en) | Sterilizing and inflammation diminishing wormwood paste and preparation method thereof | |
| CN107050298A (en) | A kind of Chinese medicine paste formulation and preparation method for treating burn and scald skin damaged | |
| CN105055689A (en) | Traditional Chinese medicine ointment for treating scalds | |
| CN105055666B (en) | A Chinese medicinal ointment for treating traumatic pyocutaneous disease and skin ulcer | |
| CN111437351A (en) | Pure traditional Chinese medicine for treating burns and scalds | |
| CN112439020A (en) | Traditional Chinese medicine composition and tincture for treating chronic eczema and preparation method thereof | |
| CN104706772A (en) | Chinese patent medicine for treating burn and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210323 |
|
| RJ01 | Rejection of invention patent application after publication |